Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-31 @ 6:40 PM
Study NCT ID:
NCT00258206
Status:
COMPLETED
Last Update Posted:
2017-12-06
First Post:
2005-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
2007-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-22
First Submit QC Date:
None
Study First Post Date:
2005-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-28
Results First Submit QC Date:
None
Results First Post Date:
2015-06-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-01
Last Update Post Date:
2017-12-06
Last Update Post Date Type:
ACTUAL